Carl Lauryssen, MD, a neurosurgeon and director of research and education at Olympia Medical Center Los Angeles, completed the first procedure using Alphatec Spine's PureGen, a highly concentrated, pure population of adult stem cells originating from bone marrow, according to a hospital news release.
Dr. Lauryssen performed the L4-S1 posterolateral fusion using the PureGen osteoprogenitor cell allograft from Alphatec Spine. PureGen is an adult stem cell that provides the osteogenic factors for bone remodeling. When applied to a musculoskeletal defect, PureGen increases the stem cells on the location, which promotes a regenerative environment.
Read the Olympia Medical Center release on PureGen.
http://www.onlineprnews.com/news/66366-1286307570-first-patient-procedure-in-the-world-using-adult-stem-cells-to-enhance-spine-surgery-outcome.html
Read other coverage on biologics in orthopedics:
- Spine Surgery Research Update: Biologics in Spine Surgery
- Beyond Traditional Surgery: Options for Knee Surgery With Better Outcomes
- Biologics: What Every Physician Should Understand Before Performing Treatment from Dr. James Gladstone of Mount Sinai medical Center
Dr. Lauryssen performed the L4-S1 posterolateral fusion using the PureGen osteoprogenitor cell allograft from Alphatec Spine. PureGen is an adult stem cell that provides the osteogenic factors for bone remodeling. When applied to a musculoskeletal defect, PureGen increases the stem cells on the location, which promotes a regenerative environment.
Read the Olympia Medical Center release on PureGen.
http://www.onlineprnews.com/news/66366-1286307570-first-patient-procedure-in-the-world-using-adult-stem-cells-to-enhance-spine-surgery-outcome.html
Read other coverage on biologics in orthopedics:
- Spine Surgery Research Update: Biologics in Spine Surgery
- Beyond Traditional Surgery: Options for Knee Surgery With Better Outcomes
- Biologics: What Every Physician Should Understand Before Performing Treatment from Dr. James Gladstone of Mount Sinai medical Center